Lifestyle
- Regular aerobic exercise
- Smoking cessation
- Stress management
Oxidized LDL · oxLDL · ox-LDL
Oxidized LDL measures the level of oxidatively modified low-density lipoprotein in the blood.
Reference ranges may vary by laboratory and are not well standardized.
Oxidized LDL (oxLDL) is a modified form of low-density lipoprotein that has undergone oxidative modification. It is a key player in the pathogenesis of atherosclerosis, a chronic inflammatory disease characterized by the accumulation of lipids and inflammatory cells within arterial walls. Researchers have found that oxLDL is taken up by macrophages through scavenger receptors, such as LOX-1, leading to the formation of foam cells, which are crucial in the development of atherosclerotic plaques. Clinically, elevated oxLDL levels are associated with increased risk of cardiovascular diseases, including coronary artery disease and stroke. It reflects the oxidative stress and inflammatory status within the body, serving as a biomarker for atherosclerotic disease progression. In the context of athletic performance and biohacking, maintaining low oxLDL levels may contribute to cardiovascular health and longevity. However, the direct impact on athletic performance is less clear, as it primarily serves as an indicator of cardiovascular risk rather than a performance metric. Caveats include potential confounders such as diet, smoking, and underlying metabolic conditions that can influence oxLDL levels. Fasting status and time of day may not significantly affect oxLDL measurements, but consistent testing conditions are recommended for accurate monitoring.
Klinische Bedeutung
Elevated oxLDL levels indicate increased oxidative stress and are associated with a higher risk of atherosclerosis and cardiovascular diseases. Low levels are generally considered favorable, reflecting lower cardiovascular risk.
Progressively rising oxLDL suggests worsening oxidative stress and increased cardiovascular risk. Retest in 3-6 months if elevated.
Falling oxLDL levels indicate improved oxidative balance and reduced cardiovascular risk.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before starting any new supplement regimen.
Testing Frequency
Annually for individuals at risk of cardiovascular disease.
Correlated with
Current research suggests that reference ranges and optimal targets for soluble LOX-1 as a biomarker for atherosclerosis remain undefined, with confounding factors such as metabolic syndrome and obesity not fully elucidated. Researchers have not yet established the precise role of genetic polymorphisms in modulating LOX-1-related disease risk. Additionally, clinical questions regarding the efficacy of LOX-1-targeted therapies and the long-term implications of elevated sLOX-1 levels in diverse populations remain unanswered.
1,084
Total Citations
6
Human/RCT
4.1
Avg. Influence
2025
Latest
Researchers studied the binding of oxidized LDL (oxLDL) to macrophages, revealing that oxidized phospholipids play a significant role in this process. They found that the persistence of receptors for oxLDL is crucial for recognizing damaged cells, which has implications for atherogenesis.
Researchers reviewed the clinical implications of oxidized LDL (oxLDL) in atherosclerosis, finding that oxLDL promotes inflammatory responses and foam cell formation. They noted that autoantibodies against oxLDL complexes may be linked to arterial thrombosis, highlighting the complex role of oxLDL in cardiovascular disease.
Gradinaru Daniela, et al. · Mechanisms of ageing and development · 2015
This review examined the relationship between oxidized LDL (oxLDL) and nitric oxide (NO) in endothelial dysfunction and aging. Researchers found that both oxLDL and NO serve as biomarkers for cardiovascular diseases and may reflect human biological age.
Key findings
This review examined the role of inflammation in atherosclerosis, highlighting how immune cells like macrophages interact with oxidized LDL (oxLDL) to contribute to plaque formation. Researchers found that macrophages can ingest oxLDL, leading to foam cell formation, which is crucial for plaque stability. The study also discussed advancements in imaging and biomarkers that enhance understanding of disease progression.
This review focused on oxidative stress and its role in various organ damages, including the impact of oxidized LDL (oxLDL). Researchers found that measuring oxidative stress, including oxLDL levels, may serve as a biomarker for organ dysfunction in conditions such as diabetes and hypertension.
This study investigated the role of LOX-1 in atherosclerosis, finding that serum levels of LOX-1 ligand containing apoB (LAB) were positively associated with carotid intima-media thickness and coronary artery disease. Researchers observed that soluble LOX-1 (sLOX-1) could serve as a better biomarker for acute coronary syndrome than traditional markers.
Researchers explored the role of LOX-1 in atherosclerosis, noting that circulating levels of soluble LOX-1 (sLOX-1) are linked to plaque rupture and acute coronary syndrome. The study highlighted genetic polymorphisms of LOX-1 that may influence the risk of atherosclerotic diseases.
Researchers reviewed the clinical applications of LOX-1-specific antibodies in diagnostics and therapeutics related to diseases like atherosclerosis. The study emphasized the need for further clinical studies to translate LOX-1 findings into effective patient care strategies.
This review discussed the controversial role of lipoprotein-X (Lp-X) in atherosclerosis, noting its lipid composition similarities to LDL. Researchers found that Lp-X could lead to more lipid accumulation than oxidized LDL in macrophages, suggesting a complex relationship with atherogenicity.
Researchers reviewed recent findings on oxidized LDL (oxLDL) receptors, particularly LOX-1, and their role in atherosclerosis. They found that targeting the oxLDL-LOX-1 axis could lead to new therapeutic strategies. Additionally, soluble LOX-1 was identified as a potential biomarker for cardiovascular disease diagnosis and prognosis.
Research publications about Oxidiertes LDL over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer